STRO Sutro Biopharma, Inc.
Healthcare$25.57-16.49%ClosedMarket Cap: $247.4M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$50.75
Target (Median)
$50.00
Target Range
$43.00 - $60.00
Upside from current price: 98.5%
Rating Distribution
2 Strong Buy9 Buy1 Hold0 Sell1 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-15 | Wedbush | upgrade | Outperform | Neutral |
| 2026-05-15 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-05-15 | Leerink Partners | maintain | Outperform | Outperform |
| 2026-04-23 | Citizens | maintain | Market Outperform | Market Outperform |
| 2026-03-25 | Deutsche Bank | maintain | Buy | Buy |
| 2026-03-24 | Wells Fargo | upgrade | Overweight | Equal Weight |
| 2026-03-24 | HC Wainwright & Co. | upgrade | Buy | Neutral |
| 2026-01-20 | Citizens | upgrade | Market Outperform | Market Perform |
| 2025-12-22 | HC Wainwright & Co. | maintain | Neutral | Neutral |
| 2025-08-12 | Wells Fargo | maintain | Equal Weight | Equal Weight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-7.32 | $38.6M | 8 |
| Sun Dec 31 | $-7.21 | $44.3M | 8 |
| Mon Dec 31 | $-6.70 | $45.2M | 6 |
| Tue Dec 31 | $-6.73 | $62.6M | 6 |